GLAXOSMITHKLINE PHARMACEUTICALS LIMITED vs WALTER HEALTHCARE PRIVATE LIMITED AND ANR

IN THE HIGH COURT OF DELHI AT NEW DELHI Date of Decision: 15th May, 2026 CS(COMM) 403/2025 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED .....Plaintiff Through: Mr. Urfee Roomi, Ms. Janaki Arun, Mr. Ayush Dixit and Ms. Angela Arora, Advocates. versus WALTER HEALTHCARE PRIVATE LIMITED AND ANR .....Defendants Through: None. CORAM: HON'BLE MS. JUSTICE JYOTI SINGH JUDGEMENT JYOTI SINGH, J. (ORAL) 1. This suit is instituted on behalf of the Plaintiff inter alia seeking a decree for permanent injunction restraining Defendants and all others acting on their behalf from manufacturing, offering for sale, selling, displaying, advertising, marketing, whether directly or indirectly any tablets and/or other medicinal or pharmaceutical products bearing Defendants’ WALPOL mark and/or any other mark deceptively similar to Plaintiff’s CALPOL and CALPOL FAST marks. 2. It is stated in the plaint that Plaintiff is a company incorporated under the Companies Act, 1913 and is a member of GSK group of companies, of which GSK plc (‘GSK’) is the parent company. Headquartered in United 3. It is stated that GSK first entered the Indian market through its distributors in 1919 and direct trade with India commenced in